Actively Recruiting
USCOM in Newly Diagnosed FGR Cases
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-02-10
100
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
CONDITIONS
Official Title
USCOM in Newly Diagnosed FGR Cases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight <10th percentile or abdominal circumference <10th percentile) in the third trimester (gestational age >27w6d)
You will not qualify if you...
- Multiple gestation
- Fetal anomalies
- Gestational diabetes or pregestational diabetes.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mount Sinai Hospital
New York, New York, United States, 10029
Actively Recruiting
Research Team
N
Nicola F Tavella, MPH
CONTACT
A
Allison Perelman, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here